SHStephen L. Harris

Stephen L. Harris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Stephen L. Harris has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • David Neil Hayes

    University of Tennessee Health Science Center UTHSC Center for Cancer Research Memphis, TN

    1 shared publication
  • Leigh B. Thorne

    Anatomic Pathology Translational Core Laboratory, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

    1 shared publication
  • Marion E. Couch

    Department of Otolaryngology–Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

    1 shared publication
  • Randall J. Kimple

    University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

    1 shared publication
  • William T. Seaman

    Department of Dental Ecology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

    1 shared publication

Latest Publications

  • Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue

    by Stephen L. Harris, Leigh B. Thorne, William T. Seaman, D. Neil Hayes, Marion E. Couch, Randall J. Kimple

    Background: The aim of this study was to examine biomolecular profiles in a cohort of young adults with squamous cell cancers (SCCs) of the oral tongue.Methods: We identified all patients aged 18 to 39 years diagnosed with SCC of the oral tongue at our institution. Immunohistochemical (IHC) staining was performed for p16INK4a, epidermal growth factor receptor (EGFR), phosphorylated‐EGFR (pEGFR), p53, and ERCC1. Human papillomavirus (HPV) testing was performed using in situ hybridization (ISH) and polymerase chain reaction (PCR). Biomarker expression and HPV status were correlated with outcomes.Results: We identified 25 patients with sufficient tumor samples. Median age at diagnosis was 30 years (range, 20–39 years). p16INK4a overexpression was observed in 11 of 25 patients, whereas HPV‐16 positivity was observed in none of the tumor samples by ISH and 2 of the tumor samples by PCR. p16INK4a positivity was correlated with improved relapse‐free survival (hazard ratio [HR] = 0.23, p = .01) and overall survival (HR = 0.28, p = .05). Neither EGFR, pEGFR, p53, nor excision repair cross‐complementing rodent repair deficiency, complementation group 1 (ERCC1) expression correlated with outcome on univariate analysis.Conclusions: p16INK4a overexpression was common and was a marker of favorable prognosis. p16INK4a overexpression was not a reliable predictor of HPV positivity in our cohort. © 2010 Wiley Periodicals, Inc. Head Neck, 2011